Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin in cystinuria
NCT04818034Phase 2Completed
- Sponsor
- University of California, San Francisco
- Start
- Aug 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dapagliflozin in cystinuria (CSNU), sponsored by University of California, San Francisco. Started Aug 2021; status: completed.
02
Drugs
dapagliflozin
03
Conditions
cystinuria (CSNU)
Beyond the preview
Go deeper on NCT04818034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04818034.